Qwell Pharmaceuticals

About:

Qwell Pharmaceuticals develops small molecule drugs that could prevent tumors and excess inflammation of skin cells.

Top Investors: ARCH Venture Partners, Wellcome Trust

Description:

Qwell's goal is to develop a new family of small-molecule drugs, derived from a plant source, that have a potent ability to fight tumors and excess inflammation of skin cells.

Total Funding Amount:

$7M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2008-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-01-06

IPO Status:

Private

Industries: